Development of methyl isoxazoleazepines as inhibitors of BET.

@article{Hewitt2015DevelopmentOM,
  title={Development of methyl isoxazoleazepines as inhibitors of BET.},
  author={M. Hewitt and Y. Leblanc and Victor S. Gehling and R. Vaswani and A. C{\^o}t{\'e} and Christopher G. Nasveschuk and Alexander M. Taylor and Jean-Christophe Harmange and J. Audia and E. Pardo and Rich Cummings and Shivangi Joshi and P. Sandy and J. Mertz and R. Sims and Louise Bergeron and B. Bryant and S. Bellon and F. Poy and H. Jayaram and Yong Tang and Brian K. Albrecht},
  journal={Bioorganic & medicinal chemistry letters},
  year={2015},
  volume={25 9},
  pages={
          1842-8
        }
}
  • M. Hewitt, Y. Leblanc, +19 authors Brian K. Albrecht
  • Published 2015
  • Medicine, Chemistry
  • Bioorganic & medicinal chemistry letters
  • In this report we detail the evolution of our previously reported thiophene isoxazole BET inhibitor chemotype exemplified by CPI-3 to a novel bromodomain selective chemotype (the methyl isoxazoleazepine chemotype) exemplified by carboxamide 23. The methyl isoxazoleazepine chemotype provides potent inhibition of the bromodomains of the BET family, excellent in vivo PK across species, low unbound clearance, and target engagement in a MYC PK-PD model. 
    15 Citations

    Figures, Tables, and Topics from this paper.

    Structure-Based Design of γ-Carboline Analogues as Potent and Specific BET Bromodomain Inhibitors.
    • 48
    Structure-based design, synthesis and in vitro antiproliferative effects studies of novel dual BRD4/HDAC inhibitors.
    • 17
    Discovery of a Potent and Selective in Vivo Probe (GNE-272) for the Bromodomains of CBP/EP300.
    • 35
    Recent advance in oxazole-based medicinal chemistry.
    • 62
    Drug Discovery Targeting Bromodomain-Containing Protein 4
    • 93

    References

    SHOWING 1-10 OF 56 REFERENCES
    Discovery, Design, and Optimization of Isoxazole Azepine BET Inhibitors.
    • 72
    • PDF
    Identification of a novel series of BET family bromodomain inhibitors: binding mode and profile of I-BET151 (GSK1210151A).
    • 114
    Optimization of 3,5-Dimethylisoxazole Derivatives as Potent Bromodomain Ligands
    • 89
    • PDF
    Fragment-based discovery of bromodomain inhibitors part 2: optimization of phenylisoxazole sulfonamides.
    • 150
    From ApoA1 upregulation to BET family bromodomain inhibition: discovery of I-BET151.
    • 85
    Fragment-based drug discovery of 2-thiazolidinones as inhibitors of the histone reader BRD4 bromodomain.
    • 92
    Naphthyridines as Novel BET Family Bromodomain Inhibitors
    • 26